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Abstract
Background—Our objective was to examine differences in hospital resource utilization for 
children with Down syndrome by age and the presence of other birth defects, particularly severe 
and non-severe congenital heart defects (CHDs).
Methods—This was a retrospective, population-based, statewide study of children with Down 
syndrome born 1998-2007, identified by the Florida Birth Defects Registry (FBDR) and linked to 
hospital discharge records for 1-10 years after birth. To evaluate hospital resource utilization, 
descriptive statistics on number of hospitalized days and hospital costs were calculated. Results 
were stratified by isolated Down syndrome (no other coded major birth defect); presence of severe 
and non-severe CHDs; and presence of major FBDR-eligible birth defects without CHDs.
Results—For 2,552 children with Down syndrome, there were 6,856 inpatient admissions, of 
which 68.9% occurred during the first year of life (infancy). Of the 2,552 children, 31.7% (n=808) 
had isolated Down syndrome, 24.0% (n=612) had severe CHDs, 36.3% (n=927) had non-severe 
CHDs, and 8.0% (n=205) had a major FBDR-eligible birth defect in the absence of CHD. Infants 
in all three non-isolated DS groups had significantly higher hospital costs compared to those with 
isolated Down syndrome. From infancy through age 4, children with severe CHDs had the highest 
inpatient costs compared to children in the other sub-groups.
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Conclusions—Results support findings that for children with Down syndrome the presence of 
other anomalies influences hospital use and costs, and children with severe CHDs have greater 
hospital resource utilization than children with other CHDs or major birth defects without CHDs.
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INTRODUCTION
Down syndrome, also known as trisomy 21, occurs in approximately 1 in 700 births (Parker 
et al., 2010). Down syndrome is often associated with impaired speech, hearing, and vision 
capabilities, and most individuals have impaired cognitive ability. In addition, 
approximately half of all individuals with Down syndrome also have a congenital heart 
defect (CHD) (Boulet et al., 2008; Freeman et al., 1998). Direct costs associated with Down 
syndrome include costs to the health care system, caregiver and psychosocial services, 
special education, loss of time from work, and out-of-pocket expenses for services, 
equipment and appliances not covered by insurance.
In a study conducted using the 2004 MarketScan Commercial claims database, researchers 
examined medical care expenditures for children ages birth through four years with and 
without Down syndrome in a privately insured population (Boulet et al., 2008). In this study, 
the mean and median expenditures for children with Down syndrome were 12 to 13 times 
higher than for children without Down syndrome and did not vary by age (Boulet et al., 
2008). In addition, researchers found mean and median expenditures to be higher for 
children with Down syndrome and a CHD than for children with Down syndrome without a 
CHD, but this varied by age; the ratio of median expenditures was 6.9 in infancy, 2.4 at ages 
one to two, and 1.3 at ages three to four (Boulet et al., 2008). While these studies provide 
important information on hospital resource utilization for young children with Down 
syndrome, few studies have examined hospitalizations and costs beyond the first few years 
of life (Baraona et al., 2013; Geelhoed et al., 2011; Zhu et al., 2013). Additionally, although 
costs associated with CHD-related hospital admissions vary widely by specific condition, 
studies of costs or expenditures associated with Down syndrome and CHDs do not generally 
stratify by CHD type (Boulet et al., 2009).
We hypothesize that hospital resource utilization is positively associated with the severity of 
the CHD among children with Down syndrome, and that this difference may vary by the 
child’s age. Our objective was to use population-based data to examine differences in 
hospital resource utilization for children with Down syndrome by age and the presence of 
other congenital anomalies, particularly severe and non-severe CHDs.
METHODS
Study population
This was a statewide, population-based, retrospective, observational study of children with 
Down syndrome born January 1, 1998, through December 31, 2007, identified by the 
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Florida Birth Defects Registry (FBDR). The FBDR is a passive, statewide, population-based 
surveillance system that identifies infants with birth defects, such as Down syndrome, from 
multiple databases of health care information (National Birth Defects Prevention Network, 
2011; Salemi et al., 2010; Salemi et al., 2011). Infants in the FBDR are ascertained during 
the first year of life, primarily using hospital discharge records from Florida’s Agency for 
Health Care Administration (AHCA) (Agency for Health Care Administration, 2011). The 
FBDR does not capture information on adopted infants, prospective adoptees, or on infants 
whose mothers delivered out-of-state (Salemi et al., 2010; Salemi et al., 2011). Infants 
included in this study were born to mothers who were residents of Florida at the time of 
delivery, had an International Classification of Disease, 9th revision; Clinical Modification 
(ICD-9-CM) code in the FBDR for Down syndrome (758.0) and had at least one inpatient 
discharge record.
Longitudinal data linkage
Historically, the FBDR datasets included birth and infancy death vital records linked to 
AHCA inpatient and outpatient visits during the first year of life for infants identified as 
having at least one FBDR-eligible ICD-9-CM code (Salemi et al., 2010; Salemi et al., 2011). 
As part of a collaborative project with the University of North Carolina at Charlotte, 
University of South Florida, Florida Department of Health, and the Centers for Disease 
Control and Prevention, a subset of FBDR infants with specific birth defects, including 
Down syndrome, was linked to AHCA discharge records beyond the first year of life. The 
longitudinal data for this project included inpatient admissions that were initiated between 
January 1, 1999, and December 31, 2008, thereby capturing up to 10 years of post-infancy 
hospital discharge records. Data linkage was conducted using a stepwise deterministic 
strategy, with linking stages constructed in a hierarchical order, ranging from highest to 
lowest confidence. For example, stage one consisted of an exact match between infant social 
security number (SSN), maternal SSN, infant’s date of birth, and infant’s sex. Subsequent 
stages included linkages based on less exact matching of infant and/or maternal SSN; 
crossover matching between infant, maternal, and paternal SSN; and “fuzzy” matching on 
date of birth (e.g., one or two day variability in infant’s date of birth, month and day are 
reversed, or day and month digits are reversed). Linking passes were run without 
replacement; when a link was established during a given stage, the record was then removed 
from the pool of available records to be linked during subsequent, lower-confidence stages. 
Linkage was conducted separately for singleton and multiple births due to the increased 
complexity of linking records for multiple births. Further details of this stepwise 
deterministic strategy previously have been described (Salemi et al., 2013a).
Hospitalizations and costs
We estimated the number of hospital admissions, number of hospitalized days, and hospital 
costs based on hospitalizations initiated, but not necessarily completed, during the periods of 
interest. From birth through age two, we examined hospitalizations in one year intervals 
(i.e., infancy, age one, and age two). During the infancy period, we also examined resource 
utilization during the birth hospitalization and post-birth hospitalizations. Inpatient 
admissions that occurred between three years old through eight years old were examined 
over two year intervals due to decreasing numbers of children with inpatient admissions in 
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the older age groups. Because of the small sample size of nine and ten-year-old children 
with inpatient admissions, we did not report these results. Multiple admission records were 
merged into one if a hospital transfer occurred (Colvin and Bower, 2009). Transfers were 
defined as inpatient admissions that occurred on the same day that the child was discharged 
from a previous hospitalization or admissions one day after a previous discharge with an 
accompanying “transfer” code.
All dollar values are reported as 2012 US dollars calculated using the Producer Price Index 
for hospitals (U.S. Bureau of Labor Statistics, 2013). We converted inpatient charges to 
estimated costs using year-specific statewide cost-to-charge ratios. Based on state-level data 
from the AHRQ Healthcare Cost and Utilization Project State Inpatient Database, the 
average all-payer inpatient hospital cost-to-charge ratio among Florida hospitals ranged 
from 0.355 in 2001 (n=209 hospitals reporting) to 0.294 in 2008 (n=217 hospitals reporting), 
suggesting hospitals’ costs averaged approximately 29%-36% of the amount those hospitals 
billed to healthcare payers during this time period (Agency for Healthcare Research and 
Quality, 2013). Because 2001 was the earliest year of data available, the cost-to-charge ratio 
for 2001 (0.355) was also used to convert inpatient charges to estimated costs for the years 
1998-2000.
Case classification
Results were stratified by isolated Down syndrome, severe CHDs, non-severe CHDs, and 
major FBDR-eligible birth defects without CHDs. We reviewed ICD-9-CM codes present in 
the database and made database-specific decisions regarding classification when multiple 
defect codes were present. Isolated Down syndrome was defined as having no other ICD-9-
CM code for any major birth defect. Down syndrome with severe CHDs, with or without 
major non-cardiac defects, was defined by the presence of an ICD-9-CM code between 
745.00-747.92 and catheterization (ICD-9 codes: 37.21-37.23, 88.42-88.44, 88.50-88.58) or 
surgical (ICD-9 codes: 35.00-35.04, 35.10-35.14, 35.20-35.28, 35.31-35.35, 35.39, 35.41, 
35.42, 35.50-35.54, 35.60-35.63, 35.70-35.73, 35.81-35.84, 35.91-35.95, 35.98, 35.99, 
36.99, 37.33, 37.5, 37.51, 37.52, 39.0, 39.21) procedure codes or death during the first year 
of life (Mahle et al., 2009). Down syndrome with all other CHDs, with or without major 
non-cardiac defects, was classified as Down syndrome with non-severe CHDs. Down 
syndrome with major FBDR-eligible birth defects without CHDs was defined by the 
presence of any major ICD-9-CM code included in the FBDR, other than those identified as 
CHD codes.
Variable construction and statistical analysis
Selected maternal demographic characteristics of interest were: age, race/ethnicity, nativity, 
parity, marital status, and education, along with two healthcare variables: principal expected 
healthcare payer at delivery and birth hospital nursery level (I, III, or III [highest]) 
(American Academy of Pediatrics Committee on Fetus and Newborn, 2004). Private payer 
included private or employer-based insurance, including Tricare. Public insurance included 
Medicare, Medicaid, and other state and local government insurance in Florida, such as the 
State’s Children’s Health Insurance Program, KidCare. The birth hospital nursery level was 
coded as the highest level in the facility (e.g., a hospital with Level II and III beds was 
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classified as Level III). Child demographics of interest included sex, preterm birth, birth 
weight, plurality, and death during infancy and childhood.
Demographic characteristics for children with Down syndrome and severe and non-severe 
CHDs, with or without non-cardiac defects, and children with major FBDR-eligible birth 
defects without CHDs were compared to children with isolated Down syndrome. Mantel-
Haenszel chi-square statistics were used to compare group differences for each characteristic 
of interest. Costs and number of hospitalized days were presented as mean (with standard 
deviation) and median (with interquartile range) estimates for the infancy period; median 
(with interquartile range) estimates only were reported for the period beyond infancy 
because the follow-up time varied for children beyond one year of age. Wilcoxon rank-sum 
tests were used to detect differences in hospital resource utilization by Down syndrome sub-
group.
RESULTS
We identified 2,715 children with ICD-9-CM codes indicating Down syndrome in the 
FBDR and born 1998-2007, with an estimated administrative birth prevalence of 12.7 per 
10,000 live births (n=2,715/2,135,000) (Florida Department of Health Birth, Florida Birth 
Defects Registry, 2011). Approximately 6.0% (n=163) did not have at least one inpatient 
discharge record and were excluded, resulting in a final sample size of 2,552. Children 
excluded from the analysis were more likely to have isolated Down syndrome, Hispanic 
mothers, foreign-born mothers, and were more likely to be twins or higher order multiples 
than children included in the analysis.
Among the 2,552 children included in the study, 808 (31.7%) had isolated Down syndrome, 
612 (24.0%) had Down syndrome with a severe CHD, 927 (36.3%) had Down syndrome 
with a non-severe CHD, and 205 (8.0%) had Down syndrome with a major birth defect in 
the absence of any CHD. Approximately 80.8% (n=1,911/2,366) of children with Down 
syndrome and available birth hospital discharge records had an ICD-9-CM for Down 
syndrome on their birth hospital discharge record. Of the remaining children, 13.2% (n=388) 
and 4.1% (n=104) had their first ICD-9-CM code for Down syndrome on post-birth hospital 
discharge records during infancy and after the child’s first birthday, respectively, and 7.8% 
(n=199) did not have an ICD-9-CM code for Down syndrome on any hospital discharge 
record. Among children with multiple admissions, 87.5% (n=1,258/1,437) had an ICD-9-
CM code for Down syndrome on at least two admissions; among those that only had one 
ICD-9-CM code for Down syndrome, the code was present on the subsequent admission for 
approximately 50.3% of these children (n=90/179).
Approximately 5.0% (n=126) of all children with Down syndrome died during infancy. Of 
these infants, 76 (60.3%) died in the hospital, with a median of 4 days hospitalized (range 
0-156 days) prior to death. An additional 2.2% (n=55) of children died in the period from 
age one through the end of the study period, December 31, 2008, with the mortality rate 
ranging from 0.9% of children one year old (n=23/2,426) to 0.2% of children seven years 
old (n=3/875); no eight-year-old children in this cohort died. Of the children that died after 
infancy, 20 (36.4%) died in the hospital, with a median of 12 days hospitalized (range 0-32 
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days) prior to death. The most common cause of death was Down syndrome (n=44, 24.3%), 
followed by atrioventricular septal defect (n=14, 7.7%) and Tetralogy of Fallot (n=13, 
7.2%).
The distributions of several maternal and infant characteristics were significantly different 
when comparing children with Down syndrome and CHDs or other major FBDR-eligible 
birth defects and children with isolated Down syndrome (Table 1). In comparison to mothers 
of children with isolated Down syndrome, mothers of children with Down syndrome and 
non-severe CHDs were more likely to be older than 35, of Hispanic ethnicity, and foreign-
born. Children with Down syndrome and major birth defects without CHDs or with severe 
CHDs were more likely to be born low birth weight, and children with Down syndrome 
major FBDR-eligible birth defects without CHDs were more likely to have been born 
preterm compared to children with isolated Down syndrome. Children with Down syndrome 
and severe CHDs, non-severe CHDs, and other major FBDR-eligible birth defects without 
CHDs were more likely to have been born in a hospital with level III nursery care. The 
mortality rate during the study period was three times higher for children with Down 
syndrome and severe CHDs and almost twice as high for children with Down syndrome and 
other major FBDR-eligible birth defects without CHDs compared to children with isolated 
Down syndrome. Children with isolated Down syndrome were twice as likely to die during 
the study period as children Down syndrome and with non-severe CHDs, although, by 
definition, infants with CHDs that died during infancy were considered to have severe 
CHDs.
There were a total of 6,856 inpatient admissions during the study period, 4,724 (68.9%) of 
which were initiated during the first 12 months of life. Approximately 14.0% (n=368) of 
infants experienced a hospital transfer at birth; an additional 61 infants (n=2.4%) 
experienced a transfer at a later time. During the first year of life, infants were hospitalized 
an average of 20.5 days (standard deviation [SD]: 32.4) with a mean estimated inpatient cost 
of $41,568 (SD: $84,572) (Table 2). Mean estimated inpatient costs during the first year of 
life for infants with severe CHDs were approximately 11 times the mean estimated inpatient 
costs for isolated Down syndrome; median costs for infants with severe CHDs were more 
than 26 times the median costs for infants with isolated Down syndrome. Mean and median 
estimated inpatient costs were two and four times higher for infants with Down syndrome 
and non-severe CHDs and four and six times higher for infants with Down syndrome and 
major FBDR-eligible birth defects without CHDs than for infants with isolated Down 
syndrome. Mean and median numbers of hospitalized days were also significantly greater 
for infants with Down syndrome and severe or non-severe CHDs or major FBDR-eligible 
birth defects without CHDs in comparison to infants with isolated Down syndrome.
Median estimated inpatient costs for all children with Down syndrome decreased with 
increasing age until age six and then increased for ages seven to eight (Table 3). However, 
there were relatively small numbers of children in the older age groups, and most likely co-
morbid conditions contributed to the inpatient resource utilization. Children with Down 
syndrome and severe and non-severe CHDs had significantly greater median inpatient costs 
for hospitalizations at age one and ages three to four in comparison to children with isolated 
Down syndrome. Beyond infancy, there were no significant differences in hospital resource 
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utilization for children with Down syndrome and major FBDR-eligible birth defects without 
CHDs compared to children with isolated Down syndrome. Median inpatient costs were 
higher for children with Down syndrome and severe CHDs than any other sub-group, 
particularly during the first two years of life (Figure 1).
DISCUSSION
This analysis described the demographics and hospital resource utilization for 2,552 Florida-
born children with Down syndrome. The mortality rate during the study period was 
significantly greater for children with Down syndrome and severe CHDs and major FBDR-
eligible birth defects without CHDs and significantly lower for children with Down 
syndrome and non-severe CHDs than for children with isolated Down syndrome. Estimated 
inpatient costs and number of hospitalized days were significantly greater for children with 
Down syndrome and severe CHDs (with or without other major FBDR-eligible birth 
defects) and for children with Down syndrome and major FBDR-eligible birth defects 
without CHDs than for children with Down syndrome and non-severe CHDs or isolated 
Down syndrome during the first year of life. Infants with severe CHDs and major FBDR-
eligible birth defects without CHDs were also significantly more likely to be born low birth 
weight than infants with isolated Down syndrome, which likely contributed to the difference 
in hospital resource utilization observed during infancy. During early childhood, inpatient 
costs were significantly greater for children with Down syndrome and severe or non-severe 
CHDs than for children with isolated Down syndrome, but this difference became less 
pronounced with increasing age.
Although our study utilized data from a single state, our findings about the importance of 
other birth defects in patterns of hospital use by children with Down syndrome were 
generally consistent with other studies. For example, a longitudinal study of linked birth 
defects surveillance and hospital discharge records in Massachusetts for children with Down 
syndrome found that during the first three years of life, total hospital days were almost twice 
as great for those with either CHDs or a non-cardiac major birth defect compared to children 
with Down syndrome without CHDs or non-cardiac birth defects (Derrington et al., 2013). 
In a 2013 study of hospitalizations among children and adults with and without Down 
syndrome, using data from the Danish health care system, researchers found that presence of 
other malformations, especially CHDs, was an important predictor of the relative frequency 
of hospital days (Zhu et al., 2013). That study examined data for all age ranges of 
individuals with Down syndrome and found that relative hospital use was greatest among 
children under the age of five years.
A study of school-aged children with Down syndrome in Western Australia observed a 
decrease in healthcare utilization for children with Down syndrome and CHDs and less 
ongoing cardiac co-morbidity in a 2004 survey compared to a 1997 survey (Thomas et al., 
2011). The authors hypothesized that this difference was due to improvements in early 
identification and surgical repair of CHDs, which is supported by our findings that the 
majority of hospital resource utilization for children with Down syndrome and CHDs 
occurred in early childhood. Researchers in a second study, using data from Western 
Australia, found that the majority of health costs for children with Down syndrome occurred 
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during the first two years of life and declined with increasing age (Geelhoed et al., 2011), 
which is consistent with our findings.
Using data from the 2004 MarketScan Commercial Database, researchers reported that 
infants with Down syndrome averaged 49 days in the hospital during the first year of life 
and had mean inpatient cost of $87,568 in 2012 dollars (Boulet et al., 2008). Both estimates 
are more than twice as large as our study’s findings of 20 hospital days and $41,568 mean 
inpatient costs. Our estimates of median inpatient costs beyond infancy, however, appear 
consistent with the estimates of mean costs in the MarketScan study.
Our findings on number of hospitalized days during infancy are consistent with a previous 
analysis from Massachusetts for 1999-2004 (Derrington et al., 2013). We found that beyond 
infancy median inpatient costs for children with Down syndrome did not differ markedly or 
consistently between those with and without other birth defects, cardiac or non-cardiac. 
Costs were higher for one-year-olds with severe CHDs. The differences in costs between 
children with Down syndrome and severe and mild CHDs after infancy are quite modest 
compared with cost differences for all children with Down syndrome and CHDs (Boulet et 
al., 2009), which could reflect differences in the spectrum of CHDs in children with Down 
syndrome.
There were several limitations for this project. The FBDR is a passive birth defects 
surveillance system, which identified infants with Down syndrome based on ICD-9-CM 
codes and did not include verbatim or clinically-verified diagnoses for Down syndrome or 
other birth defects, including CHDs (Strickland et al., 2008). We may have under-
ascertainment of children with Down syndrome that were diagnosed after infancy; an 
estimated 87% of live-born infants with Down syndrome are diagnosed postnatally and the 
timing of postnatal diagnosis varies widely, although the majority of these infants are 
diagnosed at birth (Skotko, 2005; de Groot-van der Mooren et al., 2014). Because the study 
cohort included only children with birth defects, we were unable to compare our results with 
hospital resource utilization for children without birth defects. However, our data did allow 
for comparison of hospital resource utilization among children with isolated Down 
syndrome in comparison to those with Down syndrome and CHDs or other major FBDR-
eligible birth defects. Another limitation was that the principal healthcare payer was the 
expected payer and may not have been the actual payer. In addition, there may be instances 
where two payers shared the cost of the hospitalization. We were unable to examine the 
effect to which these limitations may have influenced our results. We were also limited by 
our lack of information on the prenatal experience, including prenatal diagnosis of Down 
syndrome or other birth defects. An examination of maternal demographics indicated a 
higher proportion of Hispanic and foreign-born mothers among mothers of children with 
Down syndrome and CHDs than mothers of children with isolated Down syndrome, 
suggesting differential access to or use of prenatal care, antenatal diagnosis, or 
ascertainment (Kucik et al., 2012).
This study was also limited by the use of a statewide cost-to-charge ratio to convert inpatient 
charges to costs. This cost conversion method is most accurate when there is low variability 
in cost mark-up between hospitals and departments within a hospital (Rogowski, 1999). 
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Therefore, use of statewide cost-to-charge ratios may be problematic due to potentially wide 
variability in the difference between costs and charges by hospital and within hospital 
departments (Salemi et al., 2013b). Additionally, cost-to-charge ratios were unavailable for 
years prior to 2001, resulting in use of the 2001 ratio to impute the missing cost-to-charge 
ratios for 1998-2000. As cost-to-charge ratios have decreased over time, costs for 
hospitalizations during 1998-2000 are a slight underestimate. We also did not have 
information on professional fees as hospital discharge data only included facility fees. Based 
on an analysis of claims data from California, it was estimated that hospitalization costs per 
child could be underestimated by about one-fifth in the present analysis (Rogowski, 1998). 
In addition, some post-birth hospital visits may have occurred outside Florida and were not 
included in our analysis. The FBDR does not include linked maternal labor and delivery 
records, therefore, some birth hospitalization use and costs might have been applied to the 
mothers’ records.
This study had several strengths. The FBDR is a statewide, population-based registry and 
includes multiple sources of birth defects ascertainment. This study included a unique 
combination of registry data linked to longitudinal hospital data. Florida has a racially and 
ethnically diverse source population with a large number of annual births (Hamilton et al., 
2011). This analysis highlights the linkage between birth defects surveillance data and 
available hospital discharge records, which may be a cost-efficient approach to assessing 
resource utilization beyond infancy.
CONCLUSION
Results support findings that for children with Down syndrome the presence of other 
anomalies influences hospital use and costs, and children with Down syndrome and severe 
CHDs have greater hospital resource utilization than children with Down syndrome and 
other CHD types. Further examination of the impact of parent/household and child 
characteristics on hospital resource utilization is warranted. Our findings suggest that birth 
defects registry and hospital discharge data can provide useful tools for evaluating patterns 
of hospital use and associated costs over time.
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Trends in estimated inpatient costs for children with Down syndrome in Florida, 1998-2007. 
Isolated Down syndrome was defined as no other International Classification of Disease, 9th 
revision; Clinical Modification (ICD-9-CM) code for any major birth defect included in the 
Florida Birth Defects Registry (FBDR). CHD=congenital heart defect.
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Table 1
Selected demographic characteristics for Florida-born children with Down syndrome, 1998-2007























Parent/ household n (%) n (%) n (%) n (%) n (%)
Mother’s age, years
 < 20 172 (6.7) 66 (8.2) 41 (6.7) 49 (5.3)* 16 (7.8)
 20-24 393 (15.4) 126 (15.6) 107 (17.5) 128 (13.8) 32 (15.6)
 25-29 384 (15.1) 141 (17.5) 95 (15.5) 121 (13.1) 27 (13.2)
 30-34 508 (19.9) 165 (20.4) 116 (19.0) 175 (18.9) 52 (25.4)
 35-39 655 (25.7) 183 (22.7) 147 (24.0) 272 (29.3) 53 (25.9)
 ≥ 40 440 (17.2) 127 (15.7) 106 (17.3) 182 (19.6) 25 (12.2)
Mother’s race / ethnicity
 White, non-Hispanic 1,288 (50.4) 432 (53.5) 333 (54.4) 422 (45.5)* 101 (49.3)
 Black, non-Hispanic 514 (20.1) 147 (18.2) 134 (21.9) 185 (20.0) 48 (23.4)
 Hispanic 668 (26.2) 201 (24.9) 130 (21.2) 292 (31.5) 45 (22.0)
 Asian / Pacific Islander and American Indian / Alaskan 60 (2.4) 20 (2.5) 11 (1.8) 19 (2.1) 10 (4.9)
 Other or unknown 22 (0.9) 8 (1.0) 4 (0.7) 9 (1.0) 1 (0.5)
Mother’s nativity, foreign-born 829 (32.5) 249 (30.8) 174 (28.4) 339 (36.6)* 67 (32.7)
Mother’s parity, nulliparous 807 (31.7) 266 (32.9) 203 (33.2) 271 (29.3) 67 (32.7)
Mother’s education
 Less than high school graduate 471 (18.5) 164 (20.3) 107 (17.5) 160 (17.3) 40 (19.5)
 High school graduate or
 equivalent 807 (31.6) 236 (29.2) 211 (34.5) 295 (31.8) 65 (31.7)
 At least some college or
 university 1,255 (49.2) 404 (50.0) 288 (47.1) 467 (50.4) 96 (46.8)
 Unknown 19 (0.7) 4 (0.5) 6 (1.0) 5 (0.5) 4 (2.0)
Principal healthcare payer at birth
d
 Private 1,312 (55.5) 421 (56.4) 307 (54.6) 489 (56.4) 95 (49.7)
 Public 940 (39.7) 283 (37.9) 227 (40.4) 344 (14.5) 86 (45.0)
 Self/underinsured/charity 114 (4.8) 42 (5.6) 28 (5.0) 34 (3.9) 10 (5.2)
Birth hospital nursery care level
 I 535 (21.0) 217 (26.9) 108 (17.7)* 160 (17.3)* 50 (24.4)*
 II 693 (27.2) 253 (31.3) 140 (22.9) 254 (27.4) 46 (22.4)
 III 1,300 (51.0) 333 (41.2) 354 (57.8) 504 (54.4) 109 (53.2)
Child
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Parent/ household n (%) n (%) n (%) n (%) n (%)
 Sex, female 1,186 (46.5) 372 (46.0) 312 (51.0) 416 (44.9) 86 (42.0)
 Preterm birth (20-36 weeks) 664 (26.1) 193 (24.0) 164 (26.9) 241 (26.0) 66 (32.4)*
 Low birth weight (<2,500 g) 535 (21.0) 140 (17.3) 156 (25.4)* 183 (19.7) 56 (27.3)*
 Plurality, singleton 2,503 (98.1) 793 (98.1) 595 (97.2) 914 (98.6) 201 (98.1)
 Death during infancy 126 (4.9) 30 (3.7) 81 (13.2)* 0 (0.0) 15 (7.3)*
 Death during study period 181 (7.1) 39 (4.8) 101 (16.5)* 22 (2.4)* 19 (9.3)*
Notes. Percentages may not sum to 100% due to missing data.
*
Distribution significantly different than isolated Down syndrome, p<0.05.
a
Isolated Down syndrome = no International Classification of Disease, 9th revision; Clinical Modification (ICD-9-CM) code for any other major 
birth defect present in Florida Birth Defects Registry;
b
CHD = congenital heart defect;
c
FBDR= Florida Birth Defects Registry;
d
Private insurance includes employer-based insurance (including Tricare). Public insurance includes Medicare, Medicaid, and other state and local 
government insurance in Florida, such as the State’s Children’s Health Insurance Program (CHIP) KidCare.
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